Migraine headache relief after transcatheter closure of patent foramen ovale
Mark Reisman, MD*,
Ryan D. Christofferson, MD*,
Jill Jesurum, PhD*,*,
John V. Olsen, MD, FACC*,
Merrill P. Spencer, MD ,
Kimberly A. Krabill, MD*,
Lance Diehl, MD*,
Sheena Aurora, MD* and
William A. Gray, MD*
* Cardiovascular Research, Swedish Medical Center
Spencer Vascular Laboratories, Seattle, Washington

View larger version (20K):
[in a new window]
|
Figure 1 Migraine headache relief by migraine subtype according to presence or absence of aura. Significant relief (Significant) = 50% reduction in monthly migraine frequency. No relief (None) = <50% reduction in monthly migraine frequency. Chi-square test = 0.40, p = 0.82 for the comparison between groups. Solid bars = migraine with aura (n = 38); ruled bars = migraine without aura (n = 12).
|
|
|